Back to Search Start Over

Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct

Authors :
Lei Feng
Brijesh P Mehta
Cathy A. Sila
Demetrius K. Lopes
Todd Graves
Ashutosh P Jadhav
Ameer E Hassan
Erol Veznedaroglu
Amin Aghaebrahim
Dileep R. Yavagal
Elad I. Levy
David S Liebeskind
Marta Rubiera
Mónica Millán
Michael Chen
Wondwossen G Tekle
Nirav Vora
Michael Frankel
Marc Ribo
Anthony J. Furlan
Michael G. Abraham
Vitor Mendes Pereira
Vincent Costalat
Frank L. Silver
Ricardo A. Hanel
Roger J. Lewis
Jeffrey L. Saver
Wade S. Smith
Jean-Marc Olivot
Parita Bhuva
Amer M. Malik
Raul G Nogueira
Diogo C Haussen
Frank R Hellinger
Christophe Cognard
Ryan K. Shields
Pedro Cardona
Joey English
Brian T. Jankowitz
Tudor G Jovin
Albert J Yoo
Blaise Baxter
Peter Mitchell
Alain Bonafe
Jawad F. Kirmani
Qaisar A. Shah
Ronald F. Budzik
Département de Neuroradiologie[Montpellier]
Université Montpellier 1 (UM1)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Hôpital Gui de Chauliac [Montpellier]-Université de Montpellier (UM)
Institut des Neurosciences de Montpellier - Déficits sensoriels et moteurs (INM)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)
Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)
Université de Montpellier (UM)
Source :
New England Journal of Medicine, New England Journal of Medicine, Massachusetts Medical Society, 2018, 378 (1), pp.11--21. ⟨10.1056/NEJMoa1706442⟩, r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol, instname
Publication Year :
2018
Publisher :
Massachusetts Medical Society, 2018.

Abstract

BACKGROUND The effect of endovascular thrombectomy that is performed more than 6 hours after the onset of ischemic stroke is uncertain. Patients with a clinical deficit that is disproportionately severe relative to the infarct volume may benefit from late thrombectomy. METHODS We enrolled patients with occlusion of the intracranial internal carotid artery or proximal middle cerebral artery who had last been known to be well 6 to 24 hours earlier and who had a mismatch between the severity of the clinical deficit and the infarct volume, with mismatch criteria defined according to age (= 80 years). Patients were randomly assigned to thrombectomy plus standard care (the thrombectomy group) or to standard care alone (the control group). The coprimary end points were the mean score for disability on the utility-weighted modified Rankin scale (which ranges from 0 [death] to 10 [no symptoms or disability]) and the rate of functional independence (a score of 0, 1, or 2 on the modified Rankin scale, which ranges from 0 to 6, with higher scores indicating more severe disability) at 90 days. RESULTS A total of 206 patients were enrolled; 107 were assigned to the thrombectomy group and 99 to the control group. At 31 months, enrollment in the trial was stopped because of the results of a prespecified interim analysis. The mean score on the utility-weighted modified Rankin scale at 90 days was 5.5 in the thrombectomy group as compared with 3.4 in the control group (adjusted difference [Bayesian analysis], 2.0 points; 95% credible interval, 1.1 to 3.0; posterior probability of superiority, >0.999), and the rate of functional independence at 90 days was 49% in the thrombectomy group as compared with 13% in the control group (adjusted difference, 33 percentage points; 95% credible interval, 24 to 44; posterior probability of superiority, >0.999). The rate of symptomatic intracranial hemorrhage did not differ significantly between the two groups (6% in the thrombectomy group and 3% in the control group, P = 0.50), nor did 90-day mortality (19% and 18%, respectively; P = 1.00). CONCLUSIONS Among patients with acute stroke who had last been known to be well 6 to 24 hours earlier and who had a mismatch between clinical deficit and infarct, outcomes for disability at 90 days were better with thrombectomy plus standard care than with standard care alone. (Funded by Stryker Neurovascular; DAWN ClinicalTrials.gov number, NCT02142283.)

Details

ISSN :
15334406 and 00284793
Volume :
378
Database :
OpenAIRE
Journal :
New England Journal of Medicine
Accession number :
edsair.doi.dedup.....35aaca532102ad71e5f950999692d7b8